Company / Total Assets
Edesa Biotech, Inc. Total Assets History
FY2014-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$14.6M
FY2021
5-year range
$7.7M / $14.6M
FY2017-FY2021
Trend
+35.5%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has fluctuated over the past 7 years, ranging from $8M in FY2017 to $15M in FY2021.
Based on SEC 10-K filings.
$15M in FY2021 with a 5-year CAGR of +2.4%.
Improved from $12M to $15M over the past 3 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- +7.4%
- 5-Year CAGR
- +2.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +2.4%, indicating consistent growth.
- In FY2021, total assets increased 35.5% year-over-year.
- Lowest total assets in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | $14.6M | +35.5% |
| FY2020 | $10.8M | -8.6% |
| FY2018 | $11.8M | +52.6% |
| FY2017 | $7.7M | -40.3% |
| FY2016 | $12.9M | -10.6% |
| FY2015 | $14.5M | +70.0% |
| FY2014 | $8.5M | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026